top of page
CLDF-24-06 MASLD MASH_Wix Webcast Banner_v4.png
purple bg.png

Post Conference
Highlights from DDW


Rohit Loomba, MD, MHSc

University of California at San Diego
La Jolla, CA

Accredited Webcast!


Nadege T. Gunn, MD, CPI

Velocity Clinical Research
Waco, TX


HoChong Gilles, DNP, FNP-BC

Richmond VA Medical Center
Midlothian, VA

purple bg.png

Post Conference
Highlights from EASL


Kimberly Brown, MD

Henry Ford Health
Detroit, MI

Accredited Webcast!


Sujit Janardhan, MD, PhD

Rush University Medical Center
Chicago, IL


Patrick Horne, MSN, ARNP

University of Florida
Gainesville, FL

Program Overview and Target Audience:

The joint providership of University of Cincinnati College of Medicine (Cincinnati), Chronic Liver Disease Foundation (CLDF), and Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) presents the Expert Perspectives on MASLD/MASH: A 2024 Liver Conference Coverage Series. The initiative will feature an accredited series of livestream meetings following major liver congresses to review and discuss emerging data presented on metabolic dysfunction-associated steatotic liver disease (MASLD) and its subtype metabolic dysfunction-associated steatohepatitis (MASH). The series will be complemented by accredited archived livestreams and educational resources on CLDF’s and GHAPP’s educational portals, and, respectively, as well as GHAPP’s mobile application, where appropriate. The initiative will target health care professionals (HCPs), including gastroenterologists, hepatologists, nurse practitioners, physician assistants, and nurses.


Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Discuss emerging data for the diagnosis and monitoring of MASH

  • Analyze current and potential pharmacologic management strategies for MASH, including GLP-1 agonists

  • Integrate weight loss into MASLD/MASH disease management strategies


Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati, The Chronic Liver Disease Foundation (CLDF), and Gastroenterology & Hepatology Advanced Practice Providers (GHAPP). The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.


The University of Cincinnati designates this enduring activity a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure of Relevant Financial Relationships:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies* (commercial interests) within the last 24 months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify from involvement in the planning and implementation of accredited continuing education any individuals (1) who refuse to provide this information or (2) whose conflicts of interests cannot be mitigated.


*Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.


All relevant relationships have been mitigated prior to the commencement of this activity. The following disclosures were made:


Planning Committee Disclosures:

Lisa Pedicone, PhD- Medical Writer

No relevant financial relationships to disclose.

Rachel Bejarano, PharmD- Medical Writer

No relevant financial relationships to disclose.


All additional planning committee members, the University of Cincinnati staff and the Chronic Liver Disease Foundation (CLDF), and Gastroenterology & Hepatology Advanced Practice Providers (GHAPP)  staff have no relationships to disclose.



The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.


Off-Label Disclosure Statement:

Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.


Fee information: There is no fee for this educational activity.

Jointly provided by the University of Cincinnati, the Chronic Liver Disease Foundation (CLDF), and Gastroenterology & Hepatology Advanced Practice Providers (GHAPP).

Supported by an educational grant from Novo Nordisk Inc.

GHAPP Logo.jpg
bottom of page